Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.44 USD | -2.79% | +8.93% | -65.92% |
Mar. 28 | CASI Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 05 | Top Midday Gainers | MT |
Evolution of the average Target Price on CASI Pharmaceuticals, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering CASI Pharmaceuticals, Inc.
HC Wainwright | |
BTIG | |
Oppenheimer | |
Mizuho Securities |
EPS Revisions
- Stock Market
- Equities
- CASI Stock
- Consensus CASI Pharmaceuticals, Inc.